Sucralfate tablets are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination.
From the U.S. FDA-approved label for Sucralfate. Full label: DailyMed.
Sucralfate tablets are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.
From the U.S. FDA-approved label for Sucralfate. Full label: DailyMed.
Active Duodenal Ulcer. The recommended adult oral dosage for duodenal ulcer is 1 g four times per day on an empty stomach. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination.
Directions from the U.S. FDA-approved label for Sucralfate — your doctor or pharmacist may advise differently.
Sucralfate tablets are contraindicated in patients with known hypersensitivity reactions to the active substance or to any of the excipients.
Excerpt from the U.S. FDA-approved label for Sucralfate. Talk to a pharmacist or doctor before use.
The physician should read the "PRECAUTIONS" section when considering the use of this drug in pregnant or pediatric patients, or patients of childbearing potential. Duodenal ulcer is a chronic, recurrent disease. While short-term treatment with sucralfate can result in complete healing of the ulcer, a successful course of treatment with sucralfate should not be expected to alter the post healing frequency or severity of duodenal ulceration. Isolated reports of sucralfate tablet aspiration with accompanying respiratory complications have been received.
Warnings and precautions excerpt from the U.S. FDA-approved label for Sucralfate — not a complete list. Talk to a pharmacist or doctor before use.
Adverse reactions to sucralfate in clinical trials were minor and only rarely led to discontinuation of the drug. In studies involving over 2700 patients treated with sucralfate tablets, adverse effects were reported in 129 (4.7%). Constipation was the most frequent complaint (2%).
Excerpt from the U.S. FDA-approved label for Sucralfate — not a complete list. Talk to a pharmacist or doctor about side effects.
Store at 20° to 25°C (68° to 77°F).
Storage information from the U.S. FDA-approved label for Sucralfate.
What is Sucrafil?
Sucrafil 500mg Suspension is a Sucralfate medicine made by Fourrts India Laboratories Pvt Ltd. It comes as 500mg Suspension.
What is Sucrafil used for?
According to its FDA label, Sucralfate is tablets are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer.
What is the generic name of Sucrafil?
The generic name of Sucrafil is Sucralfate.
What are the side effects of Sucralfate?
Adverse reactions to sucralfate in clinical trials were minor and only rarely led to discontinuation of the drug. In studies involving over 2700 patients treated with sucralfate tablets, adverse effects were reported in 129 (4.7%).
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
